TWi Pharmaceuticals, Inc. v. Merck Serono SA > Summary
Court Case Number IPR2023-00049
Filing Date Oct 14, 2022
Court Patent Trial and Appeal Board
Status Trial Instituted
Administrative JudgesErica A. Franklin, Ulrike W. Jenks, Tina E. Hulse
Judge Writing the Final DecisionErica A. Franklin
Claims Challenged in the Petition: 36, 38, 39, 41, 42, 43, 44, 45, 46, 47, 48
Claims Instituted: 36, 38, 39, 41, 42, 43, 44, 45, 46, 47, 48
Petitioner
Patent Owner
Petitioner Attorneys
8TWi Pharmaceuticals, Inc.
Attorney Name: Stephen R. Howe
Husch Blackwell LLP
TWi Pharmaceuticals, Inc.
Attorney Name: Philip D. Segrest
Husch Blackwell LLP
Attorney Name: Stephen R. Howe
Husch Blackwell LLP
Attorney Name: Stephen R. Howe
Husch Blackwell LLP
TWi Pharmaceuticals, Inc.
Husch Blackwell LLP
Ivax Research, Inc.
Husch Blackwell LLP
Attorney Name: Don J. Mizerk
Husch Blackwell LLP
Patent Owner Attorneys
9MERCK SERONO SA
Attorney Name: Deric X. Geng
Wilmer Cutler Pickering Hale and Dorr
MERCK SERONO SA
Attorney Name: Emily R. Whelan
Wilmer Cutler Pickering Hale and Dorr
Attorney Name: David B. Bassett
Wilmer Cutler Pickering Hale and Dorr LLP
Attorney Name: Vinita Ferrera
Wilmer Cutler Pickering Hale and Dorr LLP
Attorney Name: Mary Pheng
Wilmer Cutler Pickering Hale and Dorr
MERCK SERONO SA
Wilmer Cutler Pickering Hale and Dorr
Attorney Name: Asher S. McGuffin
Wilmer Cutler Pickering Hale and Dorr
Attorney Name: Gillian T. Farrell
Wilmer Cutler Pickering Hale and Dorr
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 07713947 | Cladribine regimen for treating multiple sclerosis | May 11, 2010 |
